<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02822118</url>
  </required_header>
  <id_info>
    <org_study_id>Digestion-03</org_study_id>
    <nct_id>NCT02822118</nct_id>
  </id_info>
  <brief_title>Therapeutic Effect of Chang'an I Recipe on Irritable Bowel Syndrome With Diarrhea</brief_title>
  <official_title>Therapeutic Effect of Chang'an I Recipe on Irritable Bowel Syndrome With Diarrhea: A Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xiyuan Hospital of China Academy of Chinese Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xiyuan Hospital of China Academy of Chinese Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the efficacy and safety of TCM decoction Chang'an I Recipe in the treatment of
      IBS-D. A multicenter, randomized, double-blind, placebo-controlled clinical trial was
      designed. Patients were applied for central random number and were given corresponding
      treatment according to inclusion sequences.The treatment group was administered the Chang'an
      I Recipe, 150ml/bag, 3 times/day; while the control group was administered the placebo,
      150ml/bag, 3 times/day. Both courses of treatment were 8 weeks.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change of Irritable Bowel Syndrome Symptom Severity Score (IBS-SSS)</measure>
    <time_frame>IBS-SSS was evaluated by patients at 0, 2, 4 ,6 and 8 weeks.</time_frame>
    <description>Score less than 75 points was considered as in remission, 75~175 as mild, 175~300 as moderate, and over 300 as severe.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum markers regarding liver and kidney function</measure>
    <time_frame>at baseline and 8 weeks.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">216</enrollment>
  <condition>Irritable Bowel Syndrome With Diarrhea</condition>
  <arm_group>
    <arm_group_label>Chang'an I Recipe</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group were administered the Chang'an I Recipe for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients in this group were administered the placebo for 8 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chang'an I Recipe</intervention_name>
    <description>Patients in this group were administered the Chang'an I Recipe, 150ml/bag, 3 times/day for 8 weeks.</description>
    <arm_group_label>Chang'an I Recipe</arm_group_label>
    <other_name>The treatment group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Patients in this group were administered the placebo, 150ml/bag, times/day for 8 weeks.</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>The control group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients meeting the diagnostic criteria of Western medicine for IBS-D;

          -  aged 18-70 years old; with a baseline IBS-SSS score over 75 points;

          -  voluntarily signed the informed consent;

          -  local resident who could ensure follow-ups, with basic reading ability.

        Exclusion Criteria:

          -  Patients with IBS-C, -M, and uncertain forms;

          -  accompanied with serious lesions in major organs including heart, liver, and kidney,
             hematopoietic system diseases, and tumors;

          -  gastrointestinal organic disease (e.g., chronic pancreatitis), or systemic diseases
             affecting the digestive tract motion (e.g., hyperthyroidism, diabetes, chronic renal
             insufficiency, and nervous system diseases);

          -  undergoing or requiring constant use of drugs that may affect gastrointestinal
             functions (e.g., anti-cholinergic drugs, calcium channel blockers, 5-HT3 receptor
             antagonist, antidiarrheal agents, antacids, prokinetic agents, antidepressants,
             anxiolytics, and intestinal flora regulating drugs);

          -  with history of abdominal surgery (e.g., cholecystectomy);

          -  with an allergy history of tested drugs or severe allergy history of food;

          -  pregnant and lactating female;

          -  with a history of neurological or psychiatric disorders;

          -  or participating in other clinical trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>xudong Tang, Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>XiYuan Hospital of China Academy of Traditional Chinese Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Xiyuan Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100091</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wangjing Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100102</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dongzhimen Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100700</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Longhua Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zhejiang Provincial Hospital of TCM</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310006</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2016</study_first_submitted>
  <study_first_submitted_qc>July 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 4, 2016</study_first_posted>
  <last_update_submitted>September 2, 2016</last_update_submitted>
  <last_update_submitted_qc>September 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>IBS-D; Chang'an I Recipe; Placebo</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Diarrhea</mesh_term>
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

